🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G9495L125
- Market Cap
- Large Cap
- IPO
- 12/2/2022 · $5.00/share
Business: Virax Biolabs Group Ltd is a Biotechnology company focused on the diagnosis of and the detection of immune responses to viral diseases. Virax Biolabs Group Limited is currently developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats.
Company Contact
- CEO
- James Foster
- CFO
-
James Foster
- Investor Relations
- Russo Partners · 646-942-5591 · Maxim.Jacobs@russopartnersllc.com